# Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion

> **Newsylist Open Intelligence Dossier** · First detected: 2026-06-29 13:31 UTC · Category: Business · Sources: 6 · Current Velocity: 3.67

## Executive Summary
French biotech Ipsen is acquiring Kartos Therapeutics in a deal valued at up to $1.75 billion to expand its hemato-oncology pipeline.

## Intelligence Brief
Ipsen has entered an agreement to acquire Kartos Therapeutics. The deal includes an upfront payment of $450 million, with total potential value reaching up to $1.75 billion.


Coverage from Reuters, The Wall Street Journal, and Endpoints News emphasizes the financial terms of the acquisition. Fierce Biotech and GlobeNewswire note that the move expands Ipsen's late-stage hemato-oncology pipeline, specifically regarding a potential Jakafi add-on therapy for myelofibrosis.


Future developments center on the integration of Kartos' blood cancer research and the progress of the myelofibrosis therapy.

## Verified Facts & Key Claims
### How much is Ipsen paying for Kartos Therapeutics?
The deal involves an upfront payment of $450 million, with a total potential value of up to $1.75 billion.

### What is the primary therapeutic goal of this acquisition?
Ipsen aims to expand its late-stage hemato-oncology pipeline, including a potential add-on therapy for myelofibrosis to be used with Jakafi.

### What type of company is Ipsen?
According to Reuters, Ipsen is a French biotech company.

## Key People, Organizations & Locations
Billion, French, Ipsen, Kartos Therapeutics, Buy Kartos Therapeutics for Up, Kartos, Jakafi

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| FirstWord Pharma | Ipsen to pay $1.75B for Kartos and its blood cancer asset | 2026-06-29 10:44 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTFBNUDNiZzQxOHZXRnBDNGtjYjBfNmsybk9LUzVfQnN4Q2FlQXlCODFTVjZlN3RMLUJqSGpPZEQwUl9mWVhqWDdGaExUUkhwejhGMzh3?oc=5) |
| GlobeNewswire | Ipsen to acquire Kartos Therapeutics, expanding hemato-oncology late-stage pipeline | 2026-06-29 10:44 | [Source Link](https://news.google.com/rss/articles/CBMi6gFBVV95cUxOTkJaTnkycmR2TFhFamkyWXdHdGszTFlhVmlFSk01em5SenotUmFDU1pCZ3pWM1p1c052aldBd0RmQjFvcDBLY0VycE5sTGhIclFRSzdZX3VHZ2tkS0wtMnRuaV9UbDFoOGt0bS03YTFJRlFJeEprUi0xNFlvQ0dJQ0FRU3VabkNfd1lwUDlhSDJ0bVJLeWNUN204a1FXUnhqWVdJckxEanZra0g0T1poSXdQOElBLXN1NDMtaHNvV1JGMWNvQkk4a0diMkdVWWEzWjk1LTV0eXBnN2t4Nm1ITTBXWGNPVF9UNkE?oc=5) |
| Reuters | French biotech company Ipsen to buy Kartos Therapeutics for $450 million | 2026-06-29 10:44 | [Source Link](https://news.google.com/rss/articles/CBMirgFBVV95cUxPZ2IxaFRzWXJfQ2hrMVVVY2puS2VZX3A4UXFJNWJmNjhTYVNKODB4RzZXNXV3RmdPRGtEbWlfcHptUk80d2kyNEJvQ1k3NkVub05fUmVZVkk5WmE4OXVUYjVSVG5RUmFyTkFPQkpILVVrTUtaX3p5aWpPRXdBNjN4bWQtUlpKMjViSm5Ld0Jwa2xlLTRQV0tXQllCN3RQYWExWW92UDZ6eklOeE9WV1E?oc=5) |
| Endpoints News | Ipsen to buy blood cancer company Kartos Therapeutics for $450M upfront | 2026-06-29 10:44 | [Source Link](https://news.google.com/rss/articles/CBMimgFBVV95cUxQTWZmTlppN2c3Tms1Wm9hZ1JZRzI2eFlBSncydjJwUGlaTWF1TG43OU9yWmRRMGNlLWF2TVktVlVRVk1kWS1DdHRiX193cTdHcHJhZnMzT0U5RTExUGRNZVVseWs2dlJTUWwxMzgzRUpYR3BXMlNsazJJV3o5UnNPY01fYTRtaUl5OGF1Rm9xelJsZUNvcTZ5MnJB?oc=5) |
| Fierce Biotech | Ipsen pens $1.7B deal to acquire Kartos for potential Jakafi add-on therapy for myelofibrosis | 2026-06-29 10:44 | [Source Link](https://news.google.com/rss/articles/CBMitgFBVV95cUxQMTZrNW5KbEEwOEZEQlB4UENlV2ZoMHBQbjJHTWNOMVdYVmRNZDNzQUpsT1FscDRoZF85aXp0bFE3cFZLQnVUdEl2LVdKNDd5ZkNfVE15c2Q4MHpLZ25KUDJ4amYxdmhNSjhYcDAtVWZ0TmVNZG5uck5vSzBHQzV5TjR4YzRYTVBGSGpyT3ZkTWp0dE1xVFpIVE1aZjI0OXlwSGw5aHBzX0RObHNTb2hkcEx4aXM1UQ?oc=5) |
| WSJ | Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion | 2026-06-29 10:44 | [Source Link](https://news.google.com/rss/articles/CBMimwFBVV95cUxONFlHUlY3UHBjMlV6M2xtNEU0TzNkRGdjejE3ck1kZGRlaXRJRkQwVWh0MmNyRE9oTldpN3VER2p4ME9veWR3NG1VY1AxeDJaVS1pcjZuYlgtZFNfSmxsX1prUFBPZndPQXU4cW5NZzRZRXNiTWlONFhvUHFQUjdJdjRmeFptaXlnRE5qSmVPdWhkakpsQnFmS3dVSQ?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-06-29/ipsen-to-buy-kartos-therapeutics-for-up-to-1-75-billion*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*